๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
To assess the safety, tolerability and pharmacokinetics of ABT-199 in femal...
Status
Completed
Location
Site Reference ID/Investigator# 89694
Start Date
2012-11
Trial ID
NCT01686555
The purpose of this study is to investigate the safety and pharmacokinetics...
Status
Completed
Location
Clinical Trials Center, Seoul National University Hospital
Start Date
2011-05
Trial ID
NCT01348516
Treatments Being Tested
To Evaluate the Safety, Tolerability and Pharmacokinetics on DA-302168S Tab...
Status
Completed
Location
Gulou Hospital Affiliated to Nanjing Medical University
Start Date
2024-04-18
Trial ID
NCT06534320
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of VRB-103...
Status
Recruiting
Location
Nucleus Network
Start Date
2026-07-06
Trial ID
NCT07628127
This first-in-human clinical trial with a randomized, double-blind, placebo...
Status
Completed
Location
Parexel Los Angeles Early Phase Clinical Unit
Start Date
2023-12-21
Trial ID
NCT06225115
The primary purpose of this study is to assess the safety and tolerability ...
Status
Completed
Location
ICON 1255 East 3900 South
Start Date
2024-02-20
Trial ID
NCT06286033
TLL018 is developed for treatment of autoimmune and inflammatory diseases i...
Status
Completed
Location
Frontage Clinical Services, Inc.
Start Date
2020-01-26
Trial ID
NCT04243083
Treatments Being Tested
This is a phase 1, first-in-human, randomized, double-blind, placebo-contro...
Status
Completed
Location
Scientia Clinical Research Ltd
Start Date
2021-09-27
Trial ID
NCT05112159
This is a randomized, double-blind, placebo-controlled, ascending multiple ...
Status
Recruiting
Location
Beijing AnDing Hospital Capital Medical University
Start Date
2025-08-20
Trial ID
NCT07230652
This single-center, randomized, placebo-controlled, double-blind, dose-incr...
Status
Completed
Location
The Central South University Xiang Ya Hospital
Start Date
2020-05-26
Trial ID
NCT05806177
Treatments Being Tested